PDL BioPharma, Inc. Depreciation & Amortization Growth

Depreciation & Amortization Growth of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Depreciation & Amortization Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Depreciation & Amortization Growth for the quarter ending June 29, 2020 was -65.87% (a 10.97% increase compared to previous quarter)
  • Year-over-year quarterly Depreciation & Amortization Growth decreased by -208.25%
  • Annual Depreciation & Amortization Growth for 2019 was -35.85% (a 24.65% increase from previous year)
  • Annual Depreciation & Amortization Growth for 2018 was -28.76% (a -139.55% decrease from previous year)
  • Annual Depreciation & Amortization Growth for 2017 was 72.72% (a 4.47% increase from previous year)
  • Twelve month Depreciation & Amortization Growth ending June 29, 2020 was -10.26% (a -60.46% decrease compared to previous quarter)
  • Twelve month trailing Depreciation & Amortization Growth decreased by -78.0% year-over-year
Trailing Depreciation & Amortization Growth for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
-10.26% -25.95% -35.85% -46.63%
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Depreciation & Amortization Growth of PDL BioPharma, Inc.

Most recent Depreciation & Amortization Growthof PDLI including historical data for past 10 years.

Interactive Chart of Depreciation & Amortization Growth of PDL BioPharma, Inc.

PDL BioPharma, Inc. Depreciation & Amortization Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 -65.87% -59.36%
2019 -5.5% 60.85% -65.3% -65.84% -35.85%
2018 -59.17% -55.39% -2.19% 7.69% -28.76%
2017 0.24% 23.52% 501.34% 254.49% 72.72%
2016 208.3% 217.15% -50.48% -39.4% 69.61%
2015 -38.28% -34.03% -32.92% -14.59% -29.95%
2014 55.98% 19.61% 54.82% 44.56% 43.71%
2013 0.39% -8.02% -20.93% -16.77% -11.85%
2012 13.29% -3.44% 60.85% 68.26% 29.4%
2011 28.93% 62.08% 3.51% -2.44% 22.42%
2010 27.75% 306.35% 289.7% 109.94%

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.